Sarah Ford | September 19, 2013
OCRF Researchers Find Some Immune Cells Aid Cancer Growth
A new OCRF-funded study from researchers at the University of Michigan Comprehensive Cancer Center found that a subset of immune cells, called myeloid derived suppressor cells, do more harm than good by providing a niche where the cancer stem cells survive. The research is published in the journal Immunity.
Cancer stem cells are thought to be resistant to current chemotherapy and radiation treatments, and researchers believe that killing the cancer stem cells is crucial for eliminating cancer.
At the same time that these immune cells help the cancer, they also are suppressing the immune system.
>> Click here to read more.
Source: Ovarian Cancer Research Fund
Get Resources and Insights Straight To Your Inbox
Explore More Articles
Celebrating Juneteenth and Continuing to Work in Solidarity for Racial Justice, Equality, and Equity
June 19 — also known as Juneteenth, or the nation’s second Independence Day — commemorates the end of slavery in Texas, and therefore the nation,…
Is Your Company Ready to Launch a Scholarship Program This Fall?
Here’s What You Need to Know Now is the ideal time for companies to partner with a scholarship administrator – here’s why and how to…
How Much Money Does Your Company’s Emergency Assistance Fund Actually Need?
Setting up an Employee Assistance Fund (EAF) is one of the most practical ways to support employees during times of crisis. One of the first…
Get Resources and Insights Straight To Your Inbox
Receive our monthly/bi-monthly newsletter filled with information about causes, nonprofit impact, and topics important for corporate social responsibility and employee engagement professionals, including disaster response, workplace giving, matching gifts, employee assistance funds, volunteering, scholarship award program management, grantmaking, and other philanthropic initiatives.
